Author： Vera von Dossow Spies Claudia Schenk Hannes Schlesinger Sabine Christian von Heymann
Publisher： Adis International
ISSN： 1173-2563
Source： Clinical Drug Investigation, Vol.28, Iss.1, 2008-01, pp. : 17-26
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bosentan: haemodynamic role in pulmonary arterial hypertension
Inpharma, Vol. 1, Iss. 1604, 2007-01 ,pp. :
Access to resources
Recommend
Torasemide outshines furosemide in QOL stakes
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 444, 2004-01 ,pp. :
Furosemide/torasemide: Pseudoporphyria (first report with torasemide): case report
Reactions Weekly, Vol. 1, Iss. 1208, 2008-01 ,pp. :
Inpatient costs lower with torasemide than furosemide
Inpharma, Vol. 1, Iss. 1244, 2000-01 ,pp. :
Torasemide, but not furosemide may have additional benefit in CHF
Inpharma, Vol. 1, Iss. 1443, 2004-01 ,pp. :